中国药品试验突破5000例；韩国监管机构关注杠杆ETF

本文如何被排名

Signal score

0 / 100

Composite score across the factors below. Higher = stronger signal that this story matters right now.

Newsworthiness bucket

Commentary

该集群包含多个不相关的突发新闻，一个关于中国药品试验，另一个关于韩国金融监管，缺乏单一的连贯事件。

Source corroboration

Single-source cluster

Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.

Topics

other

Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.

AI-industry relevance

Low

Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.

Story freshness

99 days old

Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

完整方法见我们的编辑标准。